| 英文名稱 | Trigonelline |
|---|---|
| 中文名稱 | 葫蘆巴堿/胡蘆巴堿/1-甲基吡啶鎓-3-甲酸內鹽/1-甲基吡啶-1-鎓-3-羧酸內鹽/1-甲基吡啶-3-甲酸內鹽 |
| CAS號 | 535-83-1 |
| 分子式 | C7H7NO2 |
| 分子量 | 137.14 |
| 外觀 | 白色結晶粉末 |
| 熔點 | 234-236 °C |
| 英文名稱 | Trigonelline |
|---|---|
| 中文名稱 | 葫蘆巴堿/胡蘆巴堿/1-甲基吡啶鎓-3-甲酸內鹽/1-甲基吡啶-1-鎓-3-羧酸內鹽/1-甲基吡啶-3-甲酸內鹽 |
| CAS號 | 535-83-1 |
| 分子式 | C7H7NO2 |
| 分子量 | 137.14 |
| 外觀 | 白色結晶粉末 |
| 熔點 | 234-236 °C |
| Expression analysis of microRNAs and their target genes during experimental diabetic renal lesions in rats administered with ginsenoside Rb1 and trigonelline | ||
| 來源：SCI：PHARMAZIE | 作者：Shao, Xiaona | 備注：影響因子：0.82 |
| 引用描述 | ||
According to their fasting blood glucose values and initial body weight, diabetic rats were assigned to specific groups and treated as follows: DN group (tap water, n = 10), A group (ginsenoside Rb1, weikeqi-biotech, Sichuan, China, 40 mg/kg, n = 10), B group (trigonelline, weikeqi-biotech, Sichuan, China, 20 mg/kg, n = 10) and the C group (ginsenoside Rb1 and trigonelline, 60 mg/kg, m (ginsenoside Rb1) : m (trigonelline) = 2:1, n = 10). The control group was treated as follows: (tap water, n = 10). All rats were gavaged corresponding drugs or tap water once daily for 12 weeks. | ||
